“The future of radiation tends to be what we call stereotactic: radiation, which focuses on the tumor and applies large doses at one time as opposed to traditional radiation which is small doses over a longer time, ... There is a gamma knife that's dedicated to treating brain lesions where, instead of radiating the brain in a three-week period, it's a one-time focused, high-powered type treatment.”
David Greenwald
“Currently, there is no way of knowing the exact dose of radiation received by a tumor. And, because most organs shift inside the body depending on whether a patient is sitting or lying down, for example, the tumor also shifts. This technology will allow doctors to pinpoint the exact position of the tumor to more effectively administer radiation treatments.”
Babak Ziaie
“Lee was first thought to have a brain tumor.”
Cheryl Peters
“But they never got that far with the gall bladder. They found the tumor when they did a CT scan. That's when they found his gallstones, but they also found this cancer.”
Susan Unser
“Selective electrochemical tumor ablation can be performed on an outpatient basis and provides a relatively non-invasive and well-tolerated therapeutic option for patients with troublesome cutaneous and subcutaneous melanoma metastases.”
John Thompson
“One of the potential uses we envision is to use the ART treatment as a way to use tumor components to immunize cancer patients against their own cancer cells, ... The current problem with this treatment strategy is that the tumor gives off a variety of soluble products which we don't fully understand, but which we know wreck havoc on the immune system by suppressing its various components. If we can use the ART drugs to increase the number of newly produced T cells in cancer patients first, we can potentially improve the likelihood of getting a cancer vaccine to work.”
David McKean
“One of the potential uses we envision is to use the ART treatment as a way to use tumor components to immunize cancer patients against their own cancer cells. The current problem with this treatment strategy is that the tumor gives off a variety of soluble products which we don't fully understand, but which we know wreck havoc on the immune system by suppressing its various components. If we can use the ART drugs to increase the number of newly produced T cells in cancer patients first, we can potentially improve the likelihood of getting a cancer vaccine to work.”
